"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

NCT00114933 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDIV

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Stopping nucleosides and continuing lopinavir/ritonavir monotherapy

Sponsor

Arribas, Jose R., M.D.

Collaborators

[object Object]
[object Object]